Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Lung Cancer

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 200 articles: HTML format

Single Articles

December 2023
1. KINOSHITA F, Takada K, Wakasu S, Saito S, et al
   ASO Visual Abstract: Granzyme B (GZMB)-Positive Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma: Significance as a Prognostic Factor and Association With Immunosuppressive Proteins.
   Ann Surg Oncol. 2023;30:8290-8291.
   PubMed    
   
   
   November 2023
2. MACHADO PFA, Oliveiros B, Martins RA, Cruz J, et al
   ASO Author Reflections: Impact of a Preoperative Home-Based Exercise Program on Quality of Life After Lung Cancer Resection.
   Ann Surg Oncol. 2023 Nov 19. doi: 10.1245/s10434-023-14620.
   PubMed    
   
   
   
3. MACHADO PFA, Pimenta S, Garcia AL, Nogueira T, et al
   ASO Visual Abstract: Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.
   Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14602.
   PubMed    
   
   
   
4. MACHADO P, Pimenta S, Garcia AL, Nogueira T, et al
   Effect of Preoperative Home-Based Exercise Training on Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial.
   Ann Surg Oncol. 2023 Nov 7. doi: 10.1245/s10434-023-14503.
   PubMed     Abstract available
   
   
   
5. YANG X, Xiao Y, Hu H, Qiu ZB, et al
   Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
   Ann Surg Oncol. 2023;30:7400-7411.
   PubMed     Abstract available
   
   
   
6. KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al
   ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model.
   Ann Surg Oncol. 2023;30:7858-7859.
   PubMed    
   
   
   
7. VILLENA-VARGAS J
   Sowing the Seeds of Evasion: Lung Adenocarcinoma Plans Its Escape.
   Ann Surg Oncol. 2023;30:6972-6973.
   PubMed    
   
   
   
8. KEPENEKIAN V, Sgarbura O, Marchal F, Villeneuve L, et al
   2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma.
   Ann Surg Oncol. 2023;30:7803-7813.
   PubMed     Abstract available
   
   
   
9. KOSAI K, Masuda T, Kitagawa A, Tobo T, et al
   Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma.
   Ann Surg Oncol. 2023;30:7538-7548.
   PubMed     Abstract available
   
   
   
10. SHIKANAI S, Yamada N, Yanagawa N, Sugai M, et al
    Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
    Ann Surg Oncol. 2023;30:7527-7537.
    PubMed     Abstract available
    
    
    October 2023
11. RUCK JM, Broderick SR
    Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab.
    Ann Surg Oncol. 2023 Oct 26. doi: 10.1245/s10434-023-14356.
    PubMed    
    
    
    
12. SWANSON SJ
    Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification System-All "Segmentectomies" Are Not Created Equal.
    Ann Surg Oncol. 2023;30:6315.
    PubMed    
    
    
    
13. YAO F, Wu W, Zhu Q, Zhu Y, et al
    ASO Visual Abstract: Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification.
    Ann Surg Oncol. 2023;30:6717.
    PubMed    
    
    
    
14. ALEXANDER HR
    Perioperative Systemic Chemotherapy in Patients with Malignant Peritoneal Mesothelioma Undergoing Cytoreduction and HIPEC: Don't Put the Cart Before the Horse.
    Ann Surg Oncol. 2023;30:6301-6303.
    PubMed    
    
    
    
15. YAO F, Wu W, Zhu Q, Zhu Y, et al
    Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification.
    Ann Surg Oncol. 2023;30:6707-6716.
    PubMed     Abstract available
    
    
    September 2023
16. MATSUDA N, Yamamoto H, Habu T, Iwata K, et al
    ASO Visual Abstract: Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14311.
    PubMed    
    
    
    
17. FU F, Zhang Y, Chen H
    ASO Author Reflections: Upfront Surgery Followed by Adjuvant Therapy: An Option for IIIA-N2 Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2023 Sep 27. doi: 10.1245/s10434-023-14265.
    PubMed    
    
    
    
18. WANG T, Zhou J, Zheng Q, Wu D, et al
    ASO Visual Abstract: A Competing Risk Model Nomogram to Predict the Long-Term Prognosis of Lung Carcinoid.
    Ann Surg Oncol. 2023;30:5842.
    PubMed    
    
    
    
19. WANG K, Huang W, Chen X, Li G, et al
    Efficacy of Near-Infrared Fluorescence Video-Assisted Thoracoscopic Surgery for Small Pulmonary Nodule Resection with Indocyanine Green Inhalation: A Randomized Clinical Trial.
    Ann Surg Oncol. 2023;30:5912-5922.
    PubMed     Abstract available
    
    
    
20. XU SJ, Tu JH, Chen H, Yan RH, et al
    ASO Visual Abstract: A Multi-Institutional Study Analyzing the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio Exceeding 0.5 on the Prognosis for Pathologic Stage IA3 Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:5854-5855.
    PubMed    
    
    
    
21. XU SJ, Tu JH, Chen H, Yan RH, et al
    A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:5843-5853.
    PubMed     Abstract available
    
    
    
22. WANG T, Zhou J, Liu L
    ASO Author Reflections: Prediction of Long-Term Cancer-Specific Survival of Lung Carcinoid Patients.
    Ann Surg Oncol. 2023;30:5840-5841.
    PubMed    
    
    
    
23. WANG T, Zhou J, Zheng Q, Wu D, et al
    A Competing Risk Model Nomogram to Predict the Long-Term Prognosis of Lung Carcinoid.
    Ann Surg Oncol. 2023;30:5830-5839.
    PubMed     Abstract available
    
    
    
24. MATSUDA N, Yamamoto H, Habu T, Iwata K, et al
    Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Ann Surg Oncol. 2023 Sep 1. doi: 10.1245/s10434-023-14176.
    PubMed     Abstract available
    
    
    August 2023
25. MATSUDA N, Yamamoto H, Habu T, Takahashi K, et al
    ASO Author Reflections: Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio are Prognostic Factors in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Ann Surg Oncol. 2023 Aug 30. doi: 10.1245/s10434-023-14199.
    PubMed    
    
    
    
26. FU F, Sun W, Bai J, Deng C, et al
    Long-Term Outcomes of Selected Patients with IIIA-N2 Non-small Cell Lung Cancer Receiving Upfront Surgical Resection.
    Ann Surg Oncol. 2023 Aug 30. doi: 10.1245/s10434-023-14072.
    PubMed     Abstract available
    
    
    
27. YANG Z, Fu F, Zhang Y
    ASO Author Reflections: Long-Term Prognostic Factors for Stage IB Lung Cancer Patients: Pulmonary Groud-Glass Opacity or Visceral Pleural Invasion?
    Ann Surg Oncol. 2023 Aug 24. doi: 10.1245/s10434-023-14092.
    PubMed    
    
    
    
28. CHEN T, Cao Z, Sun Y, Huang J, et al
    Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2023 Aug 16. doi: 10.1245/s10434-023-14123.
    PubMed     Abstract available
    
    
    
29. YANG Z, Li X, Bai J, Li D, et al
    Prognostic Factors for Survival of Stage IB Non-small Cell Lung Cancer Patients: A 10-Year Follow-Up Retrospective Study.
    Ann Surg Oncol. 2023 Aug 3. doi: 10.1245/s10434-023-14016.
    PubMed     Abstract available
    
    
    
30. CALTHORPE L, Romero-Hernandez F, Casey M, Nunez M, et al
    ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival.
    Ann Surg Oncol. 2023;30:5131.
    PubMed    
    
    
    
31. CALTHORPE L, Alseidi A, Adam MA
    ASO Author Reflections: Contemporary Management Trends in Malignant Peritoneal Mesothelioma.
    Ann Surg Oncol. 2023;30:5130.
    PubMed    
    
    
    
32. CALTHORPE L, Romero-Hernandez F, Casey M, Nunez M, et al
    National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Ann Surg Oncol. 2023;30:5119-5129.
    PubMed     Abstract available
    
    
    July 2023
33. FUJIWARA T, Shien K, Matsuura M, Soh J, et al
    ASO Visual Abstract: EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery.
    Ann Surg Oncol. 2023 Jul 30. doi: 10.1245/s10434-023-14005.
    PubMed    
    
    
    
34. LI Z, Xu W, Wang J, Zhu Q, et al
    ASO Visual Abstract: Three-Dimensional-Guided Cone-Shaped Segmentectomy Versus Lobectomy for Small-Sized Non-small Cell Lung Cancer in the Middle Third Lung Field.
    Ann Surg Oncol. 2023 Jul 19. doi: 10.1245/s10434-023-13850.
    PubMed    
    
    
    
35. KALVAPUDI S, Yendamuri S
    Surgical Management of Incidentally Detected Pleural Disease in Lung Cancer Patients: A Complex Decision.
    Ann Surg Oncol. 2023 Jul 7. doi: 10.1245/s10434-023-13859.
    PubMed    
    
    
    
36. HONG Z, Bai X, Sheng Y, Cui B, et al
    Efficacy of Using Maryland Forceps Versus Electrocoagulation Hooks in RATS Lung Cancer Surgery: A Propensity Score-Matched Study.
    Ann Surg Oncol. 2023 Jul 2. doi: 10.1245/s10434-023-13813.
    PubMed     Abstract available
    
    
    June 2023
37. TIAN JY, Hao XY, Tong L, Fu Q, et al
    ASO Author Reflections: Preoperative Frailty Assessment Predicts Postoperative Adverse Outcomes in Elderly Lung Cancer Patients: A Retrospective Cohort Study.
    Ann Surg Oncol. 2023 Jun 30. doi: 10.1245/s10434-023-13737.
    PubMed    
    
    
    
38. LI Z, Xu W, Wang J, Zhu Q, et al
    Three-Dimensional Guided Cone-Shaped Segmentectomy Versus Lobectomy for Small-sized Non-Small Cell Lung Cancer in the Middle Third of the Lung Field.
    Ann Surg Oncol. 2023 Jun 28. doi: 10.1245/s10434-023-13772.
    PubMed     Abstract available
    
    
    
39. SHIEN K, Fujiwara T, Toyooka S
    ASO Author Reflections: Prognostic Impact of the Primary Tumor Resection for Lung Cancer Patients Diagnosed with Pleural Dissemination in the Perioperative Period-Importance of Biomarker-Based Treatment Decision Making.
    Ann Surg Oncol. 2023 Jun 25. doi: 10.1245/s10434-023-13808.
    PubMed    
    
    
    
40. FUJIWARA T, Shien K, Matsuura M, Soh J, et al
    EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery.
    Ann Surg Oncol. 2023 Jun 25. doi: 10.1245/s10434-023-13791.
    PubMed     Abstract available
    
    
    
41. LI Z, Wu W, Chen L
    ASO Author Reflections: Three-Dimensional-Guided Segmentectomy can be an Alternative to Lobectomy for Small-Sized Non-small Cell Lung Cancer in the Middle-Third Lung Parenchyma.
    Ann Surg Oncol. 2023 Jun 22. doi: 10.1245/s10434-023-13773.
    PubMed    
    
    
    
42. TIAN JY, Hao XY, Cao FY, Liu JJ, et al
    Preoperative Frailty Assessment Predicts Postoperative Mortality, Delirium and Pneumonia in Elderly Lung Cancer Patients: A Retrospective Cohort Study.
    Ann Surg Oncol. 2023 Jun 16. doi: 10.1245/s10434-023-13696.
    PubMed     Abstract available
    
    
    
43. XU S, He Z, Li X, He J, et al
    Lymph Node Metastases in Surgically Resected Solitary Ground-Glass Opacities: A Two-Center Retrospective Cohort Study and Pooled Literature Analysis.
    Ann Surg Oncol. 2023;30:3760-3768.
    PubMed     Abstract available
    
    
    
44. MERKELY G, Leite CBG, Newman ET, Raskin K, et al
    Venous Thromboembolic Event Following Soft Tissue Sarcoma Diagnosis is Associated with the Development of Pulmonary Metastasis.
    Ann Surg Oncol. 2023;30:3692-3699.
    PubMed     Abstract available
    
    
    May 2023
45. BRUNELLI A
    Segmentectomy is the Surgical Procedure of Choice for Peripheral Early-Stage Non-small Cell Lung Cancer (Most Likely!).
    Ann Surg Oncol. 2023 May 3. doi: 10.1245/s10434-023-13579.
    PubMed    
    
    
    
46. YANG MZ, Tan ZH, Li JB, Xie CL, et al
    ASO Visual Abstract: Comparison of Short-Term Outcomes Between Robot-Assisted and Video-Assisted Segmentectomy for Small Pulmonary Nodules-A Propensity Score Matching Study.
    Ann Surg Oncol. 2023;30:2767-2768.
    PubMed    
    
    
    
47. VALENZUELA CD, Solsky IB, Erali RA, Forsythe SD, et al
    ASO Visual Abstract: Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.
    Ann Surg Oncol. 2023;30:2676-2677.
    PubMed    
    
    
    
48. YANG MZ, Tan ZH, Li JB, Xie CL, et al
    Comparison of Short-Term Outcomes Between Robot-Assisted and Video-Assisted Segmentectomy for Small Pulmonary Nodules: A Propensity Score-Matching Study.
    Ann Surg Oncol. 2023;30:2757-2764.
    PubMed     Abstract available
    
    
    
49. YANG MZ, Yang HX
    ASO Author Reflections: Which Technique is Superior for Segmentectomy of Small Pulmonary Nodules: Robot-Assisted or Video-Assisted?
    Ann Surg Oncol. 2023;30:2765-2766.
    PubMed    
    
    
    
50. VALENZUELA CD, Solsky IB, Erali RA, Forsythe SD, et al
    Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.
    Ann Surg Oncol. 2023;30:2666-2675.
    PubMed     Abstract available
    
    
    April 2023
51. NAGANO T, Kinoshita F, Hashinokuchi A, Matsudo K, et al
    ASO Visual Abstract: Prognostic Impact of C-Reactive Protein-to-Lymphocyte Ratio in Non-small Cell Lung Cancer-A Propensity Score Matching Analysis.
    Ann Surg Oncol. 2023 Apr 8. doi: 10.1245/s10434-023-13396.
    PubMed    
    
    
    
52. MA H, Li S, Zhu Y, Zhang W, et al
    ASO Author Reflections: CT-Based Prognostic Score as an Indicator for Predicting the Survival of Patients with Synchronous Multiple Primary Lung Cancer.
    Ann Surg Oncol. 2023 Apr 7. doi: 10.1245/s10434-023-13420.
    PubMed    
    
    
    
53. RAMOS ARIAS G, Sindayigaya R, Ouaissi M, Buggisch JR, et al
    Safety and Feasibility of High-Pressure/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies.
    Ann Surg Oncol. 2023;30:2497-2505.
    PubMed     Abstract available
    
    
    March 2023
54. GONG S, Yao X
    The Combination of Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio Predicts Survival for Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2023 Mar 29. doi: 10.1245/s10434-023-13379.
    PubMed    
    
    
    
55. CHEN KN
    Factors to Consider in Surgical Resection of Pulmonary Metastatic Carcinoma.
    Ann Surg Oncol. 2023;30:1297-1298.
    PubMed    
    
    
    
56. MITZMAN B
    Is Less Really More? Sublobar Resection in the Elderly.
    Ann Surg Oncol. 2023;30:1293-1294.
    PubMed    
    
    
    
57. ITO T, Nakamura S, Kadomatsu Y, Ueno H, et al
    ASO Visual Abstract: Impact of Pleural Thickness on the Occurrence of Postoperative Complications in Patients with Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2023;30:1586.
    PubMed    
    
    
    
58. NAKAMURA S, Ito T, Chen-Yoshikawa TF
    ASO Author Reflections: Pleural Thickness in Patients with Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2023;30:1584-1585.
    PubMed    
    
    
    
59. ITO T, Nakamura S, Kadomatsu Y, Ueno H, et al
    Impact of Pleural Thickness on Occurrence of Postoperative Complications in Patients with Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2023;30:1574-1583.
    PubMed     Abstract available
    
    
    February 2023
60. NAGANO T, Kinoshita F, Hashinokuchi A, Matsudo K, et al
    Prognostic Impact of C-Reactive Protein-to-Lymphocyte Ratio in Non-small Cell Lung Cancer: A Propensity Score-Matching Analysis.
    Ann Surg Oncol. 2023 Feb 27. doi: 10.1245/s10434-023-13250.
    PubMed     Abstract available
    
    
    
61. TANG L, Yu H, Dai W, Yang X, et al
    ASO Visual Abstract: Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study.
    Ann Surg Oncol. 2023 Feb 27. doi: 10.1245/s10434-023-13209.
    PubMed    
    
    
    
62. MA H, Li S, Zhu Y, Zhang W, et al
    A Novel Prognostic Score Based on Multiple Quantitative Parameters of Chest CT for Patients with Synchronous Multiple Primary Lung Cancer: Is Solid Component Size a Better Prognostic Indicator?
    Ann Surg Oncol. 2023 Feb 23. doi: 10.1245/s10434-023-13248.
    PubMed     Abstract available
    
    
    
63. YOTSUKURA M, Muraoka Y, Yoshida Y, Nakagawa K, et al
    ASO Visual Abstract: Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:859-860.
    PubMed    
    
    
    
64. TANKEL J, Cools-Lartigue J
    Dual Image Navigation Aiding Segmentectomy for Early NSCLC: Feasible, but Useful?
    Ann Surg Oncol. 2023;30:669-671.
    PubMed    
    
    
    
65. SHIGEFUKU S, Ito H, Miura J, Kikuchi A, et al
    ASO Visual Abstract: Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.
    Ann Surg Oncol. 2023;30:841-842.
    PubMed    
    
    
    
66. CHANG SS, Yokomise H, Yokota N, Yoshida C, et al
    ASO Visual Abstract: Dual Image Navigation to Secure Surgical Margins in Thoracoscopic Segmentectomy.
    Ann Surg Oncol. 2023;30:850.
    PubMed    
    
    
    
67. SHIGEFUKU S, Ito H, Miura J, Kikuchi A, et al
    Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.
    Ann Surg Oncol. 2023;30:830-838.
    PubMed     Abstract available
    
    
    
68. SHIGEFUKU S
    ASO Author Reflections: Is SUVmax Comparable with TNM Classification 8th Edition in Early-Stage Lung Adenocarcinoma?
    Ann Surg Oncol. 2023;30:839-840.
    PubMed    
    
    
    
69. YOTSUKURA M, Muraoka Y, Yoshida Y, Nakagawa K, et al
    Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma.
    Ann Surg Oncol. 2023;30:851-858.
    PubMed     Abstract available
    
    
    
70. CHANG SS, Yokomise H, Yokota N, Yoshida C, et al
    Dual Image Navigation to Secure Surgical Margins in Thoracoscopic Segmentectomy.
    Ann Surg Oncol. 2023;30:843-849.
    PubMed     Abstract available
    
    
    January 2023
71. TANG L, Yu H, Dai W, Yang X, et al
    Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study.
    Ann Surg Oncol. 2023 Jan 19. doi: 10.1245/s10434-022-13065.
    PubMed     Abstract available
    
    
    
72. LI D, Deng C, Fu F, Bai J, et al
    Impact of Prior Cancer History on Outcomes of Resected Lung Cancer.
    Ann Surg Oncol. 2023 Jan 12. doi: 10.1245/s10434-022-12597.
    PubMed     Abstract available
    
    
    
73. LI D, Deng C, Zhang Y, Chen H, et al
    ASO Author Reflections: Individualized Management of Lung Cancer Patients with a History of Cancer: Surgery or Not Requires Comprehensive Judgment.
    Ann Surg Oncol. 2023 Jan 8. doi: 10.1245/s10434-022-12634.
    PubMed    
    
    
    December 2022
74. WU S, Wang Z, Sun J, Wu H, et al
    ASO Visual Abstract: Survival Outcomes of Sublobectomy and Lobectomy in Elderly Patients with Peripheral Solid-Dominant Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Dec 30. doi: 10.1245/s10434-022-12982.
    PubMed    
    
    
    
75. WU S, Wu H, Chen T, Shen J, et al
    ASO Author Reflections: Survival Outcomes of Sublobectomy and Lobectomy for Elderly Patients with Peripheral Solid-Dominant Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Dec 29. doi: 10.1245/s10434-022-13015.
    PubMed    
    
    
    
76. WU S, Wang Z, Sun J, Wu H, et al
    Survival Outcomes of Sublobectomy and Lobectomy in Elderly Patients with Peripheral Solid-Dominant Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Dec 15. doi: 10.1245/s10434-022-12909.
    PubMed     Abstract available
    
    
    
77. UIMONEN M, Helminen O, Bohm J, Mrena J, et al
    ASO Visual Abstract: Standard Lymphadenectomy for Esophageal and Lung Cancer: Variability in the Number of Examined Lymph Nodes Among Pathologists and Its Survival Implication.
    Ann Surg Oncol. 2022 Dec 10. doi: 10.1245/s10434-022-12886.
    PubMed    
    
    
    
78. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    Correction: Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
    Ann Surg Oncol. 2022 Dec 9. doi: 10.1245/s10434-022-12931.
    PubMed    
    
    
    
79. TAKAMOCHI K, Tsuboi M, Okada M, Niho S, et al
    ASO Visual Abstract: S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
    Ann Surg Oncol. 2022;29:8209-8210.
    PubMed    
    
    
    
80. TAKAMOCHI K, Tsuboi M, Okada M, Niho S, et al
    S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
    Ann Surg Oncol. 2022;29:8198-8206.
    PubMed     Abstract available
    
    
    November 2022
81. PENDLETON AC
    Commentary: The Role of PET Scan Uptake in Determining Prognosis in Early-Stage Lung Cancer.
    Ann Surg Oncol. 2022 Nov 28. doi: 10.1245/s10434-022-12687.
    PubMed    
    
    
    
82. UIMONEN M, Helminen O, Bohm J, Mrena J, et al
    Standard Lymphadenectomy for Esophageal and Lung Cancer: Variability in the Number of Examined Lymph Nodes Among Pathologists and Its Survival Implication.
    Ann Surg Oncol. 2022 Nov 25. doi: 10.1245/s10434-022-12826.
    PubMed     Abstract available
    
    
    
83. USUZAKI T, Takahashi K, Ishikuro M, Obara T, et al
    Letter to the Editor: Comment on ''Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer''.
    Ann Surg Oncol. 2022 Nov 16. doi: 10.1245/s10434-022-12809.
    PubMed    
    
    
    
84. SHIMADA Y
    Reply to: Letter to the Editor: Comment on ''Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer'' by Usuzaki, Takuma et al.
    Ann Surg Oncol. 2022 Nov 14. doi: 10.1245/s10434-022-12822.
    PubMed    
    
    
    
85. COURELLI AS, Sharma AK, Madlensky L, Choi YY, et al
    ASO Visual Abstract: Co-localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.
    Ann Surg Oncol. 2022;29:7551-7552.
    PubMed    
    
    
    
86. CHEN LW, Yang SM, Chuang CC, Wang HJ, et al
    ASO Visual Abstract: Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography.
    Ann Surg Oncol. 2022;29:7483-7484.
    PubMed    
    
    
    
87. COURELLI AS, Sharma AK, Sicklick JK
    ASO Author Reflections: Co-Localization of Synchronous Gastrointestinal Stromal Tumors (GISTs) and Peritoneal Mesothelioma (PM): A Case Series.
    Ann Surg Oncol. 2022;29:7549-7550.
    PubMed    
    
    
    
88. COURELLI AS, Sharma AK, Madlensky L, Choi YY, et al
    Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.
    Ann Surg Oncol. 2022;29:7542-7548.
    PubMed     Abstract available
    
    
    
89. OLIVER AL, Takahashi-Pipkin C, Wong JH, Burch AE, et al
    Disparate Access to Surgery for Operable Carcinoma of the Lung in North Carolina.
    Ann Surg Oncol. 2022;29:7485-7493.
    PubMed     Abstract available
    
    
    
90. CHEN LW, Yang SM, Chuang CC, Wang HJ, et al
    Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography.
    Ann Surg Oncol. 2022;29:7473-7482.
    PubMed     Abstract available
    
    
    October 2022
91. HERREROS-POMARES A, Doria P, Gallach S, Meri-Abad M, et al
    ASO Visual Abstract: A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Oct 28. pii: 10.1245/s10434-022-12717.
    PubMed    
    
    
    
92. LI D, Deng C, Fu F, Bai J, et al
    ASO Visual Abstract: Impact of Prior Cancer History on Outcomes of Resected Lung Cancer.
    Ann Surg Oncol. 2022 Oct 20. pii: 10.1245/s10434-022-12658.
    PubMed    
    
    
    
93. BONNER SN, He C, Clark M, Adams K, et al
    ASO Visual Abstract: Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative.
    Ann Surg Oncol. 2022 Oct 16. pii: 10.1245/s10434-022-12546.
    PubMed    
    
    
    
94. GOMBODORJ N, Azuma Y, Yokobori T, Erkhem-Ochir B, et al
    RAB11A Expression Is Associated With Cancer Aggressiveness Through Regulation of FGFR-Signaling in Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2022;29:7149-7162.
    PubMed     Abstract available
    
    
    September 2022
95. SHIMADA Y, Kudo Y, Maehara S, Amemiya R, et al
    ASO Visual Abstract: Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.
    Ann Surg Oncol. 2022 Sep 26. pii: 10.1245/s10434-022-12534.
    PubMed    
    
    
    
96. HERREROS-POMARES A, Doria P, Gallach S, Meri-Abad M, et al
    A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Sep 21. pii: 10.1245/s10434-022-12565.
    PubMed     Abstract available
    
    
    
97. HERREROS-POMARES A, Jantus-Lewintre E
    ASO Author Reflections: Key Components of the Hedgehog Signaling Pathway as Prognostic Biomarkers in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Sep 20. pii: 10.1245/s10434-022-12590.
    PubMed    
    
    
    
98. SHIMADA Y
    ASO Author Reflections: The Clinical Use of Radiomics with Artificial Intelligence in Patients with Early-Stage Lung Cancer.
    Ann Surg Oncol. 2022 Sep 13. pii: 10.1245/s10434-022-12518.
    PubMed    
    
    
    
99. WANG Z, Yang Z, Li S, Zhang J, et al
    ASO Visual Abstract: A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgical Resected Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2022 Sep 9. pii: 10.1245/s10434-022-12413.
    PubMed    
    
    
    
100. TEKE ME, Saif A, Sarvestani AL, Hernandez JM, et al
     A Phase III, Randomized, Controlled Trial Comparing Open Versus Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma.
     Ann Surg Oncol. 2022 Sep 9. pii: 10.1245/s10434-022-12488.
     PubMed    
     
     
     
101. SHIMADA Y, Kudo Y, Maehara S, Amemiya R, et al
     Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.
     Ann Surg Oncol. 2022 Sep 7. pii: 10.1245/s10434-022-12516.
     PubMed     Abstract available
     
     
     
102. WANG Y, Chen Y, Yang Z, Qian F, et al
     Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
     Ann Surg Oncol. 2022;29:5666-5678.
     PubMed     Abstract available
     
     
     
103. WANG Y, Han B
     ASO Author Reflections: Pure and Combined Surgically Resected Large Cell Neuroendocrine Carcinoma of Lung: Could They be Evaluated as a Single Entity?
     Ann Surg Oncol. 2022;29:5679-5680.
     PubMed    
     
     
     
104. KAWAKATSU S, Shimizu Y, Natsume S, Okuno M, et al
     Prognostic Significance of Intraoperative Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma: A Single-Center Experience and Systematic Review of the Literature.
     Ann Surg Oncol. 2022;29:5972-5983.
     PubMed     Abstract available
     
     
     
105. XU W, Dai W, Gao Z, Wang XS, et al
     Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery.
     Ann Surg Oncol. 2022;29:5593-5604.
     PubMed     Abstract available
     
     
     August 2022
106. BONNER SN, He C, Clark M, Adams K, et al
     Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative.
     Ann Surg Oncol. 2022 Aug 26. pii: 10.1245/s10434-022-12435.
     PubMed     Abstract available
     
     
     
107. YANG Z, Wang Z, Liu L
     ASO Author Reflections: Comprehensive Comparison of N Staging Subclassification Methods for Non-Small-Cell Lung Cancer.
     Ann Surg Oncol. 2022 Aug 21. pii: 10.1245/s10434-022-12398.
     PubMed    
     
     
     
108. WANG Z, Yang Z, Li S, Zhang J, et al
     A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients.
     Ann Surg Oncol. 2022 Aug 18. pii: 10.1245/s10434-022-12363.
     PubMed     Abstract available
     
     
     
109. CHENG X, Zeng W, Liu Y, Song Z, et al
     ASO Visual Abstract: Impact of Lymph Node Dissection on Survival and Tumor Recurrence in Patients with Resected cT1-2N0 Small-Cell Lung Cancer.
     Ann Surg Oncol. 2022 Aug 13. pii: 10.1245/s10434-022-12283.
     PubMed    
     
     
     
110. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
     ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients-Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02.
     Ann Surg Oncol. 2022 Aug 6. pii: 10.1245/s10434-022-12320.
     PubMed    
     
     
     
111. KLEMEN ND, Court CM, Fernandes MC, Walch HS, et al
     Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade.
     Ann Surg Oncol. 2022 Aug 5. pii: 10.1245/s10434-022-12095.
     PubMed     Abstract available
     
     
     July 2022
112. CHENG X, Zeng W, Liu Y, Song Z, et al
     Impact of Lymph Node Dissection on Survival and Tumor Recurrence for Patients with Resected cT1-2N0 Small Cell Lung Cancer.
     Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12215.
     PubMed     Abstract available
     
     
     
113. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
     Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
     Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12239.
     PubMed     Abstract available
     
     
     
114. BURCH AE, Wong JH, Irish WD
     ASO Author Reflections: Identifying and Understanding Disparities in Access to Surgery: Operable Lung Cancer in North Carolina.
     Ann Surg Oncol. 2022 Jul 12. pii: 10.1245/s10434-022-12179.
     PubMed    
     
     
     June 2022
115. USHITANI Y, Shimada Y, Yamada Y, Kudo Y, et al
     ASO Visual Abstract: Clinical Impact of Sarcopenia 1 Year after Surgery in Patients with Early-Stage Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2022 Jun 28. pii: 10.1245/s10434-022-12068.
     PubMed    
     
     
     
116. USHITANI Y, Shimada Y, Yamada Y, Kudo Y, et al
     Clinical Impact of Sarcopenia 1 Year After Surgery for Patients with Early-Stage Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2022 Jun 21. pii: 10.1245/s10434-022-11999.
     PubMed     Abstract available
     
     
     
117. MATSUGUMA H, Mun M, Sano A, Yoshino I, et al
     Time to Incurable Recurrence for Patients Treated With Pulmonary Metastasectomy for Colorectal Cancer.
     Ann Surg Oncol. 2022 Jun 18. pii: 10.1245/s10434-022-11904.
     PubMed     Abstract available
     
     
     
118. USHITANI Y, Shimada Y
     ASO Author Reflections: Management to Prevent Postoperative Sarcopenia in Patients with Lung Cancer.
     Ann Surg Oncol. 2022 Jun 14. pii: 10.1245/s10434-022-12026.
     PubMed    
     
     
     
119. BAILEY J, Van Haren RM
     Complementary Roles of Screening and Nodule Programs for Early Detection of Lung Cancer in Diverse Populations.
     Ann Surg Oncol. 2022 Jun 12. pii: 10.1245/s10434-022-11943.
     PubMed    
     
     
     
120. IWASAKI M, Ishihara S, Okada S, Shimegi R, et al
     ASO Visual Abstract: Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2022 Jun 3. pii: 10.1245/s10434-022-11907.
     PubMed    
     
     
     
121. IWASAKI M, Ishihara S, Okada S, Shimegi R, et al
     Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2022 Jun 2. pii: 10.1245/s10434-022-11835.
     PubMed     Abstract available
     
     
     May 2022
122. DONINGTON JS
     Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care.
     Ann Surg Oncol. 2022 May 27. pii: 10.1245/s10434-022-11915.
     PubMed    
     
     
     
123. IWASAKI M, Ishihara S, Inoue M
     ASO Author Reflections: Clinical Significance of Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2022 May 25. pii: 10.1245/s10434-022-11886.
     PubMed    
     
     
     
124. KUO SW, Chen PH, Lu TP, Chen KC, et al
     ASO Visual Abstract: Primary Tumor Resection for Stage IV Non-Small-Cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
     Ann Surg Oncol. 2022 May 15. pii: 10.1245/s10434-022-11687.
     PubMed    
     
     
     
125. KHAN TM, Verbus EA, Gandhi S, Heymach JV, et al
     Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR).
     Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11627.
     PubMed    
     
     
     
126. TEKE ME, Sarvestani AL, Hernandez JM, Fernando HC, et al
     A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).
     Ann Surg Oncol. 2022 May 6. pii: 10.1245/s10434-022-11584.
     PubMed    
     
     
     
127. DONINGTON JS
     The Increasing Role of Surgery in Comprehensive Treatment of Advanced Non-small Cell Lung Cancer with Targetable Mutations.
     Ann Surg Oncol. 2022 May 6. pii: 10.1245/s10434-022-11764.
     PubMed    
     
     
     
128. DHANASOPON AP, Boffa DJ
     Defining Relevancy in Patient-Reported Outcomes for Lung Cancer Surgery.
     Ann Surg Oncol. 2022 May 3. pii: 10.1245/s10434-022-11797.
     PubMed    
     
     
     
129. YUN JK, Kim YH
     ASO Author Reflections: Could VAMLA be a Therapeutic Strategy in Selected Patients with Left-sided NSCLC?
     Ann Surg Oncol. 2022;29:2840-2841.
     PubMed    
     
     
     April 2022
130. KUO SW, Chen PH, Lu TP, Chen KC, et al
     Correction to: Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
     Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11714.
     PubMed    
     
     
     
131. CUI C, Lian B, Zhang X, Wu D, et al
     An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
     Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11670.
     PubMed     Abstract available
     
     
     March 2022
132. CHEN PH, Kuo SW, Chen JS
     ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.
     Ann Surg Oncol. 2022 Mar 21. pii: 10.1245/s10434-022-11487.
     PubMed    
     
     
     
133. KUO SW, Chen PH, Lu TP, Chen KC, et al
     Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
     Ann Surg Oncol. 2022 Mar 7. pii: 10.1245/s10434-022-11483.
     PubMed     Abstract available
     
     
     
134. KEPENEKIAN V, Peron J, You B, Bonnefoy I, et al
     Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
     Ann Surg Oncol. 2022;29:2104-2113.
     PubMed     Abstract available
     
     
     
135. KEPENEKIAN V, Peron J, You B, Glehen O, et al
     ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection.
     Ann Surg Oncol. 2022;29:2114-2115.
     PubMed    
     
     
     February 2022
136. WANKHEDE D, Grover S
     ASO Visual Abstract: Outcomes Following Curative Metastasectomy for Patients with Malignant Melanoma: A Systematic Review and Meta-Analysis.
     Ann Surg Oncol. 2022 Feb 21. pii: 10.1245/s10434-022-11391.
     PubMed    
     
     
     
137. WANG ZN, Jiang XB, Lu J, Guo XY, et al
     Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study.
     Ann Surg Oncol. 2022 Feb 18. pii: 10.1245/s10434-022-11365.
     PubMed     Abstract available
     
     
     
138. LIU C, Wang W, Mei J, Zhu Y, et al
     Uniportal Thoracoscopic Single-Direction Basal Subsegmentectomy (Left S10a+ci): Trans-Inferior-Pulmonary-Ligament Approach.
     Ann Surg Oncol. 2022;29:1389-1391.
     PubMed     Abstract available
     
     
     January 2022
139. KRUMEICH LN, Roses RE, Kuo LE, Lindeman BM, et al
     ASO Visual Abstract: Survival After Adrenalectomy for Metastatic Lung Cancer.
     Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-021-11282.
     PubMed    
     
     
     
140. YUN JK, Yoo S, Lee GD, Choi S, et al
     Comparison of Long-Term Outcomes Between Minimally Invasive Pulmonary Resection With and Without Video-Assisted Mediastinoscopic Lymphadenectomy for Left-Sided Lung Cancer.
     Ann Surg Oncol. 2022 Jan 13. pii: 10.1245/s10434-021-11191.
     PubMed     Abstract available
     
     
     
141. SUN C, Anraku M, Kawahara T, Karasaki T, et al
     Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients With Non-Small Cell Lung Cancer.
     Ann Surg Oncol. 2022 Jan 8. pii: 10.1245/s10434-021-11024.
     PubMed     Abstract available
     
     
     
142. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
     Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
     Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11160.
     PubMed     Abstract available
     
     
     
143. KRUMEICH LN, Roses RE, Kuo LE, Lindeman BM, et al
     Survival After Adrenalectomy for Metastatic Lung Cancer.
     Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11192.
     PubMed     Abstract available
     
     
     
144. KARUSH JM
     Segmentectomy...Because We Can or Because We Should?
     Ann Surg Oncol. 2022;29:28-29.
     PubMed    
     
     
     
145. DAI W, Mu Y, Chang S, Wu Z, et al
     ASO Author Reflections: Using Patient-Reported Outcomes to Compare Thoracoscopic Segmentectomy and Lobectomy.
     Ann Surg Oncol. 2022;29:557-558.
     PubMed    
     
     
     
146. LI Z, He W, Wang C
     ASO Author Reflections: A Simple Method to Predict Risk Factors of Complications After Pneumonectomy.
     Ann Surg Oncol. 2022;29:570-571.
     PubMed    
     
     
     December 2021
147. HANDA Y, Tsutani Y, Okada M
     ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function.
     Ann Surg Oncol. 2021;28:8356-8357.
     PubMed    
     
     
     
148. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
     Postoperative Pulmonary Function After Complex Segmentectomy.
     Ann Surg Oncol. 2021;28:8347-8355.
     PubMed     Abstract available
     
     
     
149. CHIANG XH, Lu TP, Hsieh MS, Tsai TM, et al
     Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:8398-8411.
     PubMed     Abstract available
     
     
     
150. LEE G, Yoon S, Ahn B, Kim HR, et al
     ASO Visual Abstract: Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
151. CHIANG XH, Lu TP, Hsieh MS, Tsai TM, et al
     ASO Visual Abstract: Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
152. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
     ASO Visual Abstract: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
153. SHIGEFUKU S
     Reply to "Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients" by Guowei Che et al.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     
154. WANG Y, Che G
     Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients.
     Ann Surg Oncol. 2021;28.
     PubMed    
     
     
     November 2021
155. SUN C, Anraku M, Nakajima J
     ASO Author Reflections: An Evolving Skeletal Muscle Profiling-Towards Precise Host Phenotype and Prognostic Stratification in Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11025.
     PubMed    
     
     
     
156. SUN C, Anraku M, Kawahara T, Karasaki T, et al
     ASO Visual Abstract: Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients with Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11071.
     PubMed    
     
     
     
157. VAN JOOLINGEN WH, Rasing MJA, Peters M, van Lindert ASR, et al
     ASO Visual Abstract: Non-small Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection-can Chemoradiotherapy Offer Similar Survival?
     Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11061.
     PubMed    
     
     
     
158. JOHANSON H, Okereke I
     The Importance of Clinical Decision-Making in Surgical Planning for Non-Small Cell Lung Cancer.
     Ann Surg Oncol. 2021 Nov 8. pii: 10.1245/s10434-021-11027.
     PubMed    
     
     
     
159. DAI W, Chang S, Pompili C, Qiu B, et al
     Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small-cell Lung Cancer.
     Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10946.
     PubMed     Abstract available
     
     
     
160. LEE G, Yoon S, Ahn B, Kim HR, et al
     Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:7279-7290.
     PubMed     Abstract available
     
     
     
161. SUGARBAKER PH
     ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma.
     Ann Surg Oncol. 2021;28:7118-7119.
     PubMed    
     
     
     
162. MIMAE T, Saji H, Okada M
     ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?
     Ann Surg Oncol. 2021;28:7228-7229.
     PubMed    
     
     
     October 2021
163. VAN JOOLINGEN WH, Rasing MJA, Peters M, van Lindert ASR, et al
     Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?
     Ann Surg Oncol. 2021 Oct 30. pii: 10.1245/s10434-021-10982.
     PubMed     Abstract available
     
     
     
164. DAI W, Chang S, Pompili C, Qiu B, et al
     ASO Visual Abstract: Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2021 Oct 23. pii: 10.1245/s10434-021-10963.
     PubMed    
     
     
     
165. HANDA Y, Tsutani Y, Okada M
     Reply to "Lobe-Specific Lymph Node Dissection for Lung Cancer: Is It Still Feasible?" by Han-Yu Deng.
     Ann Surg Oncol. 2021 Oct 9. pii: 10.1245/s10434-021-10684.
     PubMed    
     
     
     
166. SHI Y, Wu S, Ma S, Lyu Y, et al
     Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
     Ann Surg Oncol. 2021 Oct 6. pii: 10.1245/s10434-021-10857.
     PubMed     Abstract available
     
     
     
167. ZHU Y, Xia L, Liu C, Lin F, et al
     Uniportal Single-Direction Thoracoscopic Right S9 Segmentectomy: Trans-Inferior-Pulmonary-Ligament Approach.
     Ann Surg Oncol. 2021;28:6407.
     PubMed     Abstract available
     
     
     
168. NISHINO T, Toba H, Yoshida T, Inoue S, et al
     Endobronchial Ultrasound Improves the Diagnosis of the Tracheobronchial Invasion of Advanced Esophageal Cancer.
     Ann Surg Oncol. 2021;28:6398-6406.
     PubMed     Abstract available
     
     
     
169. LEPPELMANN KS, Levesque VM, Bunck AC, Cahalane AM, et al
     Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
     Ann Surg Oncol. 2021;28:5829-5839.
     PubMed     Abstract available
     
     
     
170. LI S, Qiao S, Li N, Zhu X, et al
     MiR-744 Functions as an Oncogene Through Direct Binding to c-Fos Promoter and Facilitates Non-small Cell Lung Cancer Progression.
     Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10688.
     PubMed     Abstract available
     
     
     
171. LEPPELMANN KS, Fintelmann FJ
     ASO Author Reflections: Percutaneous Image-Guided Ablation and Multi-modality Management of Lung Metastases.
     Ann Surg Oncol. 2021;28:5840-5841.
     PubMed    
     
     
     September 2021
172. WEI X, Yu H, Dai W, Mu Y, et al
     Correction to: Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
     Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10798.
     PubMed    
     
     
     
173. HANDA Y, Tsutani Y, Okada M
     ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection.
     Ann Surg Oncol. 2021 Sep 3. pii: 10.1245/s10434-021-10037.
     PubMed    
     
     
     August 2021
174. DENG HY
     Lobe-Specific Lymph Node Dissection for Lung Cancer: Is it Still Feasible?
     Ann Surg Oncol. 2021 Aug 21. pii: 10.1245/s10434-021-10671.
     PubMed    
     
     
     
175. WANG C, Wang S, Li Z, He W, et al
     ASO Visual Abstract: A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-small Cell Lung Cancer Patients.
     Ann Surg Oncol. 2021 Aug 3. pii: 10.1245/s10434-021-10542.
     PubMed    
     
     
     
176. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
     Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
     Ann Surg Oncol. 2021;28:4542-4550.
     PubMed     Abstract available
     
     
     
177. ZHAO ZR, Long H
     ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
     Ann Surg Oncol. 2021;28:4551-4552.
     PubMed    
     
     
     July 2021
178. WANG C, Wang S, Li Z, He W, et al
     A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-Small Cell Lung Cancer Patients.
     Ann Surg Oncol. 2021 Jul 28. pii: 10.1245/s10434-021-10504.
     PubMed     Abstract available
     
     
     
179. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
     Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
     Ann Surg Oncol. 2021 Jul 3. pii: 10.1245/s10434-021-10020.
     PubMed     Abstract available
     
     
     
180. FU X, Wang F, Su X, Luo G, et al
     Endobronchial Ultrasound Improves Evaluation of Recurrent Laryngeal Nerve Lymph Nodes in Esophageal Squamous Cell Carcinoma Patients.
     Ann Surg Oncol. 2021;28:3930-3938.
     PubMed     Abstract available
     
     
     
181. KIM IA, Hur JY, Kim HJ, Park JH, et al
     Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:3983-3993.
     PubMed     Abstract available
     
     
     
182. KIM IA, Kim WS, Lee KY
     ASO Author Reflections: CTNNB1 and Fusion Genes as Predictors for Recurrence in Resected Early-Stage Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:3994-3995.
     PubMed    
     
     
     June 2021
183. CHIANG XH, Lin MW, Hsu HH, Chen JS, et al
     ASO Author Reflection: Comparing Wedge Resection and Segmentectomy as the Appropriate Surgical Method in cT1N0 Lung Cancer.
     Ann Surg Oncol. 2021 Jun 5. pii: 10.1245/s10434-021-10214.
     PubMed    
     
     
     
184. NAKAMURA A, Kondo N, Nakamichi T, Hashimoto M, et al
     Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
     Ann Surg Oncol. 2021;28:3057-3065.
     PubMed     Abstract available
     
     
     
185. MATSUBARA T, Okamoto T
     ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC.
     Ann Surg Oncol. 2021;28:3055-3056.
     PubMed    
     
     
     May 2021
186. WEI X, Yu H, Shi Q
     ASO Author Reflections: Using Patient-Reported Outcomes to Evaluate Surgical Approaches for Locally Advanced Lung Cancer.
     Ann Surg Oncol. 2021 May 15. pii: 10.1245/s10434-021-10018.
     PubMed    
     
     
     
187. LOTZE MT, Dhupar R
     ASO Author Reflection: Viruses, the Lung, and Thoracic Neoplasms: Breaking Bad.
     Ann Surg Oncol. 2021;28:2728-2729.
     PubMed    
     
     
     April 2021
188. MIMAE T, Saji H, Nakamura H, Okumura N, et al
     Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
     Ann Surg Oncol. 2021 Apr 26. pii: 10.1245/s10434-021-09835.
     PubMed     Abstract available
     
     
     
189. WEI X, Yu H, Dai W, Mu Y, et al
     Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
     Ann Surg Oncol. 2021 Apr 20. pii: 10.1245/s10434-021-09981.
     PubMed     Abstract available
     
     
     
190. GOOSEMAN MR, Brunelli A
     Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery.
     Ann Surg Oncol. 2021 Apr 16. pii: 10.1245/s10434-021-10039.
     PubMed    
     
     
     
191. KANTOR T, Wakeam E
     Landmark Trials in the Surgical Management of Mesothelioma.
     Ann Surg Oncol. 2021;28:2037-2047.
     PubMed     Abstract available
     
     
     
192. CHEN D, Ding Q, Wang W, Wang X, et al
     Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II-IIIA Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:2088-2098.
     PubMed     Abstract available
     
     
     
193. KAGIMOTO A, Tsutani Y, Okada M
     ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection.
     Ann Surg Oncol. 2021;28:2076-2077.
     PubMed    
     
     
     
194. KAGIMOTO A, Tsutani Y, Handa Y, Mimae T, et al
     Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:2068-2075.
     PubMed     Abstract available
     
     
     February 2021
195. BATCHELOR T, Hasan J, Macbeth F, Shackcloth M, et al
     Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal Cancer.
     Ann Surg Oncol. 2021 Feb 15. pii: 10.1245/s10434-020-09521.
     PubMed     Abstract available
     
     
     
196. VAN VEENENDAAL LM, Bertolli E, Korse CM, Klop WMC, et al
     The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
     Ann Surg Oncol. 2021;28:1019-1028.
     PubMed     Abstract available
     
     
     January 2021
197. SHIGEFUKU S, Shimada Y
     ASO Author Reflections: Impact of Ground-Glass Opacity Components in Long-Term Survivors with Resected Lung Adenocarcinoma.
     Ann Surg Oncol. 2021;28:157-158.
     PubMed    
     
     
     
198. OHTSUKA T
     Importance of Ground-Glass Opacity in Long-Term Survivors of Lung Adenocarcinoma: A Leopard Cannot Change Its Spots.
     Ann Surg Oncol. 2021;28:14-15.
     PubMed    
     
     
     October 2020
199. DEMMY TL
     The Musician, Instrument, or Orchestra?
     Ann Surg Oncol. 2020;27:4088-4090.
     PubMed    
     
     
     
200. JUNG W, Cho S
     ASO Author Reflections: Understanding Subsolid Lung Adenocarcinoma with Cystic Airspaces (LACA).
     Ann Surg Oncol. 2020;27:4404.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.